Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000301 · ClinicalTrials.gov registry record · Phase 2
Rapid Evaluation of Amantadine for Treatment of Cocaine Abuse/Dependence - 4
A Phase 2 study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00000301: Completed Phase 2 study, sponsored by University of California, Los Angeles.
NCT00000301 is a Phase 2 study that has completed, run by University of California, Los Angeles. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00000301, a Phase 2 study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
The purpose of this study is to empirically test a series of medications to: 1) determine each medication's efficacy in treatment of cocaine abuse/dependence; 2) find most effective dose range for each medication. In this study, amantadine is tested."
Interventions
- DRUG Amantadine
Trial Details
| Field | Value |
|---|---|
| Start Date | 1996-03 |
| Phase | Phase 2 |
What the finished NCT00000301 record still lists
NCT00000301 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Amantadine is the first listed.
NCT00000301 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00000301 about?
NCT00000301 is a clinical study titled "Rapid Evaluation of Amantadine for Treatment of Cocaine Abuse/Dependence - 4". The purpose of this study is to empirically test a series of medications to: 1) determine each medication's efficacy in treatment of cocaine abuse/dependence; 2) find most effective dose range for each medication. In this study, amantadine is tested."
What is the current status of trial NCT00000301?
This trial is currently completed. It is a Phase 2 study. The study started on 1996-03.
What interventions are being tested in trial NCT00000301?
The interventions under investigation include: Amantadine (DRUG).
Who is sponsoring clinical trial NCT00000301?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia